1,4-Dihydro-6,7-Dinitro-2,3-Quinoxalinedione
98%
- Product Code: 58987
CAS:
2379-57-9
| Molecular Weight: | 252.14 g./mol | Molecular Formula: | C₈H₄N₄O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00069257 | |
| Melting Point: | > 300 °C | Boiling Point: | |
| Density: | Storage Condition: | room temperature |
Product Description:
Used primarily in neuroscience research, this compound acts as a selective antagonist for glutamate receptors, particularly the NMDA receptor subtype. It is instrumental in studying the role of glutamate in synaptic transmission, plasticity, and excitotoxicity. Researchers utilize it to explore neurological disorders such as epilepsy, stroke, and neurodegenerative diseases. Its ability to block NMDA receptors helps in understanding the mechanisms underlying memory, learning, and neuronal damage. Additionally, it serves as a valuable tool in pharmacological studies to develop therapeutic agents targeting glutamate-related pathways.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Faint Yellow to Yellow Powder |
| PURITY | 97.5-100 |
| ANALYSISANHYDROUS | 21.7 % 22.7 % |
| PROTON NMR SPECTRUM | Conforms to Structure |
| SOLUBILITY IN DMSO | Yellow clear(10mg/ml |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | £68.53 |
+
-
|
| 0.050 | 10-20 days | £167.37 |
+
-
|
1,4-Dihydro-6,7-Dinitro-2,3-Quinoxalinedione
Used primarily in neuroscience research, this compound acts as a selective antagonist for glutamate receptors, particularly the NMDA receptor subtype. It is instrumental in studying the role of glutamate in synaptic transmission, plasticity, and excitotoxicity. Researchers utilize it to explore neurological disorders such as epilepsy, stroke, and neurodegenerative diseases. Its ability to block NMDA receptors helps in understanding the mechanisms underlying memory, learning, and neuronal damage. Additionally, it serves as a valuable tool in pharmacological studies to develop therapeutic agents targeting glutamate-related pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :